Impact of atrial fibrillation on levels of high-sensitivity troponin I in a 75-year-old population

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 75, Issue 4, 2015, Pages 308-313

  Horjen, Anja W ^a   Ulimoen, Sara R ^a   Enger, Steve ^a   Berge, Trygve ^a   Ihle Hansen, Hakon ^a   Norseth, Jon ^b   Tveit, Arnljot ^a  

^a VESTRE VIKEN HOSPITAL TRUST   (Norway)

^b VESTRE VIKEN HOSPITAL TRUST   (Norway)

Author keywords

Biomarkers; Cardiac arrhythmia; Cardiology; Cardiovascular diseases; Cohort studies; Immunoassays

Indexed keywords

TROPONIN I;

AGED; ARTICLE; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GERIATRIC PATIENT; GROUPS BY AGE; HEART FAILURE; HUMAN; HYPERTENSION; IMMUNOLOGY TEST KIT; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POPULATION; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SINUS RHYTHM; TRANSIENT ISCHEMIC ATTACK; BLOOD; COMPLICATION; CORONARY ARTERY DISEASE; METABOLISM; MULTIVARIATE ANALYSIS; RISK FACTOR;

AGED; ATRIAL FIBRILLATION; CORONARY DISEASE; FEMALE; HEART FAILURE; HUMANS; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTORS; SEX FACTORS; TROPONIN I;

EID: 84928792863     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2015.1011224     Document Type: Article

References (23)

1. Wolf PA, Dawber T R, Thomas HE Jr, Kannel WB. Epidemiologic assessment of chronic atrial fi brillation and risk of stroke: the Framingham study. Neurology. 1978; 28: 973-7
2. Benjamin EJ, Wolf PA, Dagostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fi brillation on the risk of death: the Framingham Heart Study. Circulation. 1998; 98: 946-52
3. Friberg L, Bergfeldt L. Atrial fi brillation prevalence revisited. J Intern Med. 2013; 274: 461-8
4. Tveit A, Abdelnoor M, Enger S, Smith P. Atrial fi brillation and antithrombotic therapYin a 75-year-old population. Cardiology. 2008; 109: 258-62
5. hijazi Z, Oldgren J, Siegbahn A, Granger CB, Wallentin L. Biomarkers in atrial fi brillation: aclinical review. Eur Heart J 2013; 34: 1475-80
6. Tveit A SI, Grundvold I, Abdelnoor M, Smith P, Arnesen H. Effect of candesartan and various infl ammation markers on maintenance of sinus rhythm after electrical cardioversion for atrial fi brillation. Am JCardiol. 2007; 99: 1544-8
7. Tveit A, Seljeflot I, Grundvold I, Abdelnoor M, Smith P, Arnesen H. Levels of PAI-1 anDoutcome after electrical cardioversion for atrial fi brillation. Thromb Res. 2008; 121: 447-53
8. Tveit A, Seljeflot I, Grundvold I, Abdelnoor M, Arnesen H, Smith P. Candesartan, NT-proBNP and recurrence of atrial fi brillation after electrical cardioversion. Int JCardiol. 2009; 131: 234-9
9. Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin Iand Tassay 99th percentile values from acommon presumably healthy population. Clin Chem. 2012; 58: 1574-81
10. Omland T, Pfeffer M A, Solomon S D, de Lemos J A, Rosjo H, Saltyte Benth J, Maggioni A, Domanski MJ, Rouleau JL, Sabatine MS, Braunwald E. Prognostic value of cardiac troponin Imeasured with ahighly sensitive assaYin patients with stable coronary artery disease. J Am Coll Cardiol. 2013; 61: 1240-9
11. White HD. Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis?. J Am Coll Cardiol. 2011; 57: 2406-8
12. Rubini Gimenez M, Twerenbold R, Reichlin T, Wildi K, Haaf P, Schaefer M, Zellweger C, Moehring B, Stallone F, Sou SM, Mueller M, Denhaerynck K, Mosimann T, Reiter M, Meller B, Freese M, Stelzig C, Klimmeck I, Voegele J, Hartmann B, Rentsch K, Osswald S, Mueller C. Direct comparison of high-sensitivity-cardiac troponin I vs. Tfor the early diagnosis of acute myocardial infarction. Eur Heart J 2014; 35: 2303-11
13. eggers K M, Lind L, Ahlstrom H, Bjerner T, Ebeling Barbier C, Larsson A, Venge P, Lindahl B. Prevalence and pathophysiological mechanisms of elevated cardiac troponin Ilevels in apopulation-based sample of elderly subjects. Eur Heart J 2008; 29: 2252-8
14. eggers KM, Venge P, Lindahl B, Lind L. Cardiac troponin Ilevels measured with ahigh-sensitive assaYincrease over time and are strong predictors of mortalitYin an elderly population. J Am Coll Cardiol. 2013; 61: 1906-13
15. hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, Hohnloser SH, Reilly PA, Vinereanu D, Siegbahn A, Yusuf S, Wallentin L. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fi brillation: aRandomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) substudy. Circulation. 2012; 125: 1605-16
16. hijazi Z, Siegbahn A, Andersson U, Granger C B, Alexander JH, Atar D, Gersh BJ, Mohan P, Harjola VP, Horowitz J, Husted S, Hylek EM, Lopes RD, McMurray JJ, Wallentin L. High-sensitivity troponin Ifor risk assessment in patients with atrial fi brillation: insights from the Apixaban for Reduction in Stroke anDother Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Circulation. 2014; 129: 625-34
17. Rienstra M, Yin X, Larson MG, Fontes JD, Magnani JW, McManus DD, McCabe EL, Coglianese EE, Amponsah M, Ho JE, Januzzi JL Jr, Wollert KC, Fradley MG, Vasan RS, Ellinor PT, Wang TJ, Benjamin EJ. Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin Iand incident atrial fi brillation. Am Heart J 2014; 167: 109-15.e2
18. Gupta K, Pillarisetti J, Biria M, Pescetto M, Abu-Salah TM, Annapureddy C, Ryschon K, Dawn B, Lakkireddy D. Clinical utility and prognostic signifi cance of measuring troponin Ilevels in patients presenting to the emergency room with atrial fi brillation. Clin Cardiol. 2014; 37: 343-9
19. hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, Hohnloser SH, Reilly PA, Siegbahn A, Yusuf S, Wallentin L. Importance of persistentelevation of cardiac biomarkers in atrial fi brillation: a RE-LY substudy. Heart. 2014; 100: 1193-200
20. Collinson PO, Heung Y M, Gaze D, Boa F, Senior R, Christenson R, Apple FS. Infl uence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem. 2012; 58: 219-25
21. FredAbJ, Tang WH, Van Lente F, Peacock WF, Francis GS. Cardiac troponins in renal insuffi ciency: review and clinical implications. J Am Coll Cardiol. 2002; 40: 2065-71
22. Venge P, Johnston N, Lindahl B, James S. Normal plasma levels of cardiac troponin Imeasured by the high-sensitivity cardiac troponin Iaccess prototype assay and the impact on the diagnosis of myocardial ischemia. J Am Coll Cardiol. 2009; 54: 1165-72
23. Lippi G. The mystifying nomenclature of cardiac troponin immunoassays. Scand J Clin Lab Invest. 2014; 74: 273-7